Edition:
India

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

1.79USD
12 Dec 2017
Change (% chg)

$-0.04 (-2.19%)
Prev Close
$1.83
Open
$1.84
Day's High
$1.84
Day's Low
$1.74
Volume
41,821
Avg. Vol
86,963
52-wk High
$13.24
52-wk Low
$1.20

Chart for

About

HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications... (more)

Overall

Beta: --
Market Cap(Mil.): $21.52
Shares Outstanding(Mil.): 11.45
Dividend: --
Yield (%): --

Financials

BRIEF-HTG Molecular Diagnostics reports third quarter earnings

* HTG Molecular Diagnostics reports 2017 third quarter earnings

08 Nov 2017

BRIEF-HTG Molecular Diagnostics receives ISO 13485 certification for Health Canada CMDCAS requirements​

* HTG Molecular Diagnostics Inc - ‍HTG Molecular Diagnostics receives ISO 13485 certification for Health Canada CMDCAS requirements​ Source text for Eikon: Further company coverage:

18 Sep 2017

BRIEF-HTG Molecular Diagnostics provides regulatory update for its HTG EdgeSeq ALKPlus Assay

* HTG Molecular Diagnostics provides regulatory update for its HTG EdgeSeq ALKPlus Assay

11 Sep 2017

BRIEF-HTG Molecular Diagnostics Q2 loss per share $0.60

* HTG Molecular Diagnostics reports second quarter 2017 results

09 Aug 2017

BRIEF-Novo Holdings reports 12.03 pct stake in HTG Molecular Diagnostics as on July 3

* Novo Holdings A/S reports 12.03 percent stake in HTG Molecular Diagnostics Inc as on July 3, 2017 - sec filing‍​

20 Jul 2017

BRIEF-HTG Molecular Diagnostics has launched new HTG EdgeSeq PATH Assay

* Has launched its new HTG EdgeSeq path assay for sale in U.S. and Europe Source text for Eikon: Further company coverage:

29 Jun 2017

BRIEF-HTG Molecular Diagnostics Inc enters statement of work with subsidiary of QIAGEN N.V

* HTG Molecular Diagnostics Inc - effective June 14, co entered statement of work with subsidiary of Qiagen N.V

15 Jun 2017

Earnings vs. Estimates